(Q53516920)

15 May 2018

title

High level of fatigue in lymphoma patients treated with high dose therapy. (English)

1 reference

15 May 2018

2

Loge JH

1 reference

15 May 2018

7

Kaasa S

1 reference

15 May 2018

Knobel H

1

1 reference

15 May 2018

Nordøy T

3

1 reference

15 May 2018

Kolstad AL

4

1 reference

15 May 2018

Espevik T

5

1 reference

15 May 2018

Kvaløy S

6

1 reference

15 May 2018

publication date

1 June 2000

1 reference

15 May 2018

Journal of Pain and Symptom Management

published in

1 reference

15 May 2018

volume

19

1 reference

15 May 2018

issue

6

1 reference

15 May 2018

page(s)

446-456

1 reference

15 May 2018

Long-term sequelae of autologous bone marrow or peripheral stem cell transplantation for lymphoid malignancies

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900144-5

7 January 2021

Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high-dose versus standard-dose chemotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900144-5

7 January 2021

Quality of life in adult cancer patients treated with bone marrow transplantation--a review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900144-5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900144-5

7 January 2021

Do patients who are treated with stem cell transplantation have a health-related quality of life comparable to the general population after 1 year?

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900144-5

7 January 2021

Energy level and sleep quality following bone marrow transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900144-5

7 January 2021

The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900144-5

7 January 2021

Physical and psychosocial functioning in patients undergoing autologous bone marrow transplantation--a prospective study.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900144-5

7 January 2021

Quality of life of 125 adults surviving 6-18 years after bone marrow transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900144-5

7 January 2021

The quality of life in adult survivors of allogeneic bone marrow transplantation. Correlates and comparison with matched renal transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900144-5

7 January 2021

Development of a fatigue scale.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900144-5

7 January 2021

Fatigue in the general Norwegian population: normative data and associations

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900144-5

7 January 2021

Hodgkin's disease survivors more fatigued than the general population.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900144-5

7 January 2021

Fatigue in cancer patients: a review of the literature.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900144-5

7 January 2021

Fatigue in cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900144-5

7 January 2021

Fatigue in systemic lupus erythematosus. Prevalence and relation to disease expression.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900144-5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900144-5

7 January 2021

Ovarian function after autologous bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900144-5

7 January 2021

Fatigue syndromes: a comparison of chronic "postviral" fatigue with neuromuscular and affective disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900144-5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900144-5

7 January 2021

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900144-5

7 January 2021

A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900144-5

7 January 2021

The release of soluble p55 TNF receptor from U937 cells studied by a new p55 immunoassay

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900144-5

7 January 2021

Interpreting the significance of changes in health-related quality-of-life scores.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900144-5

7 January 2021

Psychosocial problems among survivors of Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900144-5

7 January 2021

Quality of life following bone marrow transplantation: a comparison of patient reports with population norms.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900144-5

7 January 2021

Serum soluble tumour necrosis factor receptor 55 is increased in patients with haematological neoplasias and is associated with immune activation and weight loss

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900144-5

7 January 2021

Tumor necrosis factor ligand-receptor system can predict treatment outcome in lymphoma patients

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900144-5

7 January 2021

Elevated circulating levels of TNFalpha and its p55 soluble receptor are associated with an adverse prognosis in lymphoma patients

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900144-5

7 January 2021

Dysregulated expression of tumor necrosis factor in chronic fatigue syndrome: interrelations with cellular sources and patterns of soluble immune mediator expression

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900144-5

7 January 2021

Chronic fatigue syndrome: clinical condition associated with immune activation

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900144-5

7 January 2021

Serum Levels of Lymphokines and Soluble Cellular Receptors in Primary Epstein-Barr Virus Infection and in Patients with Chronic Fatigue Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900144-5

7 January 2021

Asthenia: an important symptom in cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900144-5

7 January 2021

Long-term endocrine toxicity of myeloablative treatment followed by autologous bone marrow/blood derived stem cell transplantation in patients with malignant lymphohematopoietic disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900144-5

7 January 2021

Oestradiol and testosterone implants

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900144-5

7 January 2021

What do cancer patients mean when they complain of concentration and memory problems?

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900144-5

7 January 2021

The quality of life of long-term survivors of Hodgkin's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900144-5

7 January 2021

Fatigue and psychiatric morbidity among Hodgkin's disease survivors

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900144-5

7 January 2021

10.1016/S0885-3924(00)00144-5

Identifiers

DOI

1 reference

15 May 2018

1 reference

15 May 2018